Association between the leptin receptor gene polymorphism and lipoprotein profile in Chinese type 2 diabetes
Hongyun Lu,Jiazhong Sun,Yancheng Xu,Danhong Xie,Liao Sun,Xiaochun Shu
DOI: https://doi.org/10.1016/j.dsx.2007.09.008
2007-01-01
Abstract:Results The frequency of the mutant A allele was 57% in diabetic patients versus 56% in normal glucose tolerances controls. The distribution of the three genotypes in control group was as follows: GG genotype, 36.0%; GA genotype, 15.3%; and AA genotype, 48.7%. This genotype distribution did not differ between control subjects and type 2 diabetic patients in which 33.3% were GG, 18.3% were GA and 48.4% were AA ( χ 2 = 1.17, P > 0.05). Plasma leptin levels were significantly higher in the diabetic patients (35.72 ± 2.85) than those in NGT subjects (8.67 ± 0.35) , but there was no statistical difference between LEPR genotypes and plasma leptin levels in the diabetic patients or in NGT control subjects. However in type 2 diabetic groups, AA genotype at nucleotide 3057 had higher levels of TG and LDL-C, and lower levels of HDL-C ( P < 0. 01). Conclusion The LEPR G3057A mutation was common in the Chinese population, this polymorphism was not associated with the glucose metabolic parameters and plasma leptin levels in Chinese subjects, but positively associated with plasma TG and LDL-C levels, negatively associated with plasma HDL-C levels in Chinese diabetic patients. It may contribute to the onset of type 2 diabetes by regulating lipid metabolism and affecting the distribution of local body mass. Keywords Leptin Leptin receptor Genetics Type 2 diabetes mellitus Lipoprotein Introduction Adipose tissue plays a crucial role in the regulation of energy homeostasis, insulin sensitivity, and lipid/carbohydrate metabolism. These actions are mediated by the actions of a number of hormones, there are three main adipocyte hormones produced in adipocytes, they are leptin, acylation stimulating protein (ASP), and adiponectin. Leptin has been shown to stimulate glucose uptake and fatty acid oxidation in skeletal muscle [1,2] , to prevent lipid accumulation in nonadipose tissues such as skeletal muscle, liver, and pancreatic-cells [3] , it has been shown to have a major influence on lipid and lipoprotein metabolism through leptin receptors (LEPR). Mutations in the leptin gene resulting in leptin deficiency cause obesity, insulin resistance, and diabetes in animals [4] . Mutations resulting in a deficient leptin receptor cause obesity and diabetes in animals [5,6] and obesity in humans [7] . Common variants in the human LEPR gene have been associated with hyperinsulinemia [8,9] , type 2 diabetes [8] , obesity, and leptin levels [10–13] . The regulatory role of leptin on lipid metabolism was known, but the relationship between leptin, LEPR gene polymorphism and plasma lipid profile varies with different genetic population. A study in Pakistan diabetic postmenopausal women discovered that non-significant correlation existed between leptin and lipid levels in normal and diabetic patients. Significant negative correlation existed between leptin and HDL ( r = −0.30) in diabetic patients [14] . A study in Thai obese and overweight subjects discovered that serum leptin level was positively associated with HDL-C and negatively with LDL-C/HDL-C [15] . Another study in Nauruan males reported that Ob-R Pro1019Pro (G3057A) polymorphism was associated with serum insulin levels and not associated with serum lipid profile levels [16] . These conflicting results may be due in part to differences in the genetic backgrounds of the studied populations. These results prompted us to explore the association between LEPR gene G3057A polymorphism in exon 20, plasma leptin levels and lipoprotein profile in Chinese population. Materials and methods Subjects About 186 unrelated Chinese patients with type 2 diabetes mellitus and 150 controls were recruited. Diabetes mellitus was diagnosed according to the criteria published by the World Health Organization in 1999. They had no evidence of current acute illness including clinically significant infectious disease. The duration of diabetes was 9.6 ± 2.7 year (range 0–32 year). An age matched normal glucose tolerance (NGT) controls ( n = 150, mean age 59.3 ± 6.82 years, 77 males, 73 females) were recruited at the routine healthy examination. Plasma parameters determination Fasting blood samples were obtained for measurement of glucose, HbA1c, and lipid levels. Routine clinical biochemical analyses were performed in the hospital laboratory. Plasma glucose was measured with glucose oxidase method. Plasma triglycerides (TG), total cholesterol (TC), high-density lipoprotein-cholesterol (HDL-C), apolipoprotein AI, apolipoprotein B were measured with oxides method by automatic biochemistry instrument, Low-density lipoprotein-cholesterol (LDL-C) was calculated using Friedewald's formula [17] . Plasma insulin was measured using a two-site immunoradiometric assay. Serum leptin levels were determined by a kit obtained from DRG Instruments (Germany) and the samples were analyzed with ELISA [18] . Genetic analysis Genomic DNA was extracted from peripheral blood leukocytes by the phenol chloroform method. Hemi-nest PCR was performed on the genomic DNA samples with a Gene Amp PCR kit (Promega) and primers as previously reported [19] . The primers were as follows: P 0 , 5′-ACTGTGGTCTCTCTACTTTC-3′; P 1 , 5′-TTTGATAGAGAAGC ACTTGG-3; P 2 , 5′-CCATGAGCTATTAGAGAAAGAATCCGTCAA-3′. The PCR mixture contained 1 μmol/L of each primer (P 0 /P 2 ), 2U of Taq polymerase, 25 mmol/L MgCl 2 , 0.2 mol/L of each dNTP and 1 μg of DNA template in a final volume of 50 μL. The application was carried out in a PCR thermal cycler (Beijing Technique Institute) with procedures as follows: denaturation at 95 °C (8 min), 30 cycles of denaturation at 94 °C (60 s), annealing at 55 °C (50 s) and extension at 72 °C (50 s), followed by a final extension step at 72 °C for 7 min. Five microliters PCR product was used for hemi-nested PCR amplified by primer P 1 and P 2 . The 276 bp PCR product (10 μL) was digested with the restriction enzyme Hinc II at 37 °C for 3–4 h in the buffer recommended by the manufacturer. Hinc II can recognize the G-to-A substitution in the fragments. The PCR product fragment derived from the G allele can be digested by Hinc II into 248 and 28 bp fragments, whereas the fragments of the same length from the A allele cannot be digested by Hin cII. Subjects homozygous for the mutation showed a DNA fragment of 276 bp, whereas homozygous subjects without it showed two DNA fragments of 248 and 28 bp. Heterozygous subjects showed three DNA fragments of 276, 248, and 28 bp. The Hin cII-treated PCR fragments were analyzed by 8% polyacrylamide gel electrophoresis at 85 W for 6–8 h and visualized with silver nitrate. Statistical analysis All statistical analyses were conducted by using the SPSS statistical package, version 10.0. Distributions of continuous variables in groups were expressed as mean ± S.D., and compared by Student's t -tests or one-way analysis of variance (ANOVA). Categorical variables were compared between groups by use of χ 2 test. A value of P < 0.05 was considered significantly. Results Clinical and biological characteristics of the study population The clinical and biological characteristics of these subjects were summarized in Table 1 . There were no significant differences in age, sex, and body mass index between the two groups. However, as expected, patients with diabetes had higher values for plasma triglycerides, cholesterol, leptin, systolic and diastolic blood pressure, but lower values for plasma HDL cholesterol levels and insulin. Distribution of LEPR genotypes in Chinese normal glucose tolerance controls population and type 2 diabetic patients The three LEPR genotypes for Pro-to-Pro nonsense mutation (GG, GA, and AA) were diagnosed by digestion of the 276 bp PCR products by Hinc II. In the screening of 150 Chinese normal glucose tolerance controls people, the allele frequency of the A mutation was 56.0%, comparable to that (86%) of a Japanese population. The distribution of the three genotypes in control group was as follows: GG genotype, 36.0%; GA genotype, 15.3%; and AA genotype, 48.7%. This genotype distribution was compatible with the Hardy–Weinberg equilibrium and was nearly identical to the distribution in type 2 diabetic patients in which 33.3% were GG, 18.3% were GA and 48.4% were AA ( Table 2 ). There was no significant difference in genotype distribution between type 2 diabetic patients and control group ( χ 2 = 1.17, P > 0.05). The absence of significant difference in frequencies of mutant genotypes in the total group of patients with type 2 diabetes and normal glucose tolerance control group indicated that LEPR G3057A gene polymorphism was not involved in the etiology of diabetes. Result of PCR direct sequence analysis Hemi-nested PCR product fragment was 99 bp which including G3057A mutation point ( Fig. 1 ), its nucleotide sequence was the same as gene bank data exclude 3057 nucleotide (GenBank accession no. 001003680 ). Correlation between LEPR genotype and plasma leptin levels Plasma leptin levels were determined in the diabetic patients and NGT control ( Table 1 ). Plasma leptin levels were significantly higher in the diabetic patients (35.72 ± 2.85) than those in NGT subjects (8.67 ± 0.35), which was coherent with the previous studies. There was no statistical difference between LEPR three genotype and plasma leptin levels in the diabetic patients or in NGT control subjects ( Fig. 2 ). LEPR G3057A polymorphism had no effect on plasma leptin levels. Association of gene polymorphism of LEPR with lipoprotein profile in Chinese type 2 diabetes We examined the distribution of the LEPR genotypes and plasma lipid profile in diabetic patients and analysed their relationship, then found that: those who carried with AA genotype had significantly higher plasma TG and LDL-C levels (2.67 ± 0.78 vs. 2.26 ± 0. 67, 4.01 ± 0. 39 vs. 3. 55 ± 0. 47) ( P < 0. 01) and lower plasma HDL-C levels ( P < 0.01) than those with the GG or GA genotype ( Table 3 ). No significant change was observed in the rest of other lipid parameters. No significant correlation existed between LEPR genotypes and plasma lipid levels in NGT subjects. The effect of LEPR G3057A polymorphism on plasma lipid profile was evident only in diabetic patients but not in NGT controls. Discussion Nowadays above 30 single nucleotide polymorphisms in the human LEPR gene have been detected, but the frequencies of LEPR gene mutations and its relationship with glucose and lipid metabolism vary among racial and ethnic groups. Van der Vleuten et al. [20] reported that Gln223Arg polymorphism in the LEPR gene was associated with Familial combined hyperlipidemia (FCH), which was supported by a significant association between HDL-C levels and the LEPR gene. Wang et al. reported that G-2548A polymorphism of the leptin gene but not Gln223Arg (Q223R) polymorphism of the leptin receptor (LEPR) gene was correlated with extreme obesity in Taiwanese aborigines [21] . In the Korean population ( n = 1463), Park et al. [22] genotyped for 11 polymorphisms (including G3057A) of LEPR and discovered that no significant associations between the genetic polymorphisms in the LEPR gene and the risk of T2DM were detected. However, one non-synonymous SNP in exon 3, +5193G > A (Arg109Lys), showed marginal association with BMI ( P = 0.02) and gene dose-dependent genetic effects were observed. LEPR G3057A polymorphism exists only in the Ob-Rb isoform, which caused silent mutation (Pro1019Pro), it is located in the intracellular domain which is involved in the interactions with Janus-activated kinase (JAKs) and signal transducers and activators of transcription (STATs) [23] . Accordingly, the G3057A variant might interfere with leptin receptor signaling. In a study of Japanese population showed that: although, individually, the Arg223Gln and the G3057A polymorphisms were not significantly associated with insulin resistance, the haplotype of these polymorphisms were associated with insulin resistance [24] . LEPR Arg223Gln polymorphism was associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men. Subjects with the Arg/Arg homozygotes had significantly lower serum HDL-C levels than those with the Arg/Gln heterozygote and Gln/Gln homozygotes [25] . In Caucasian nuclear families, Liu et al. [26] reported that three single nucleotide polymorphisms (SNPs), namely Lys109Arg (A/G), Lys656Asn (G/C), Pro1019Pro (G/A), contribute to variation in obesity phenotypes. In Chinese population, Liu et al. reported that in obesity children ( n = 72), the frequency of gene variation at 3057 nucleotide G → A transversion was higher than healthy children ( n = 60), the concentration of serum TG and the BMI and %fat of the A/A genotype obesity children were higher than those of the G/G genotype ones ( P < 0.01) but the level of serum HDL-C of the A/A children were lower than that of the G/G children [27] . However, the variant frequency of LEPR G3057A polymorphism and its association with type 2 diabetes and plasma lipid profile in Chinese population are still unknown. The present study showed that plasma leptin levels were significantly higher in diabetic patients than in NGT control, suggested that it was leptin resistance but not leptin deficiency existed in type 2 diabetic patients, which was coherent with the previous studies. LEPR G3057A polymorphism had no effect on plasma leptin levels, which was coherent with the previous study in Mexican adolescents [28] , but it may affect lipid profile in type 2 diabetic patients. Those who carried with AA genotype had significantly higher plasma TG and LDL-C levels and lower plasma HDL-C levels than those with the GG or GA genotype at nucleotide 3057. A possible explanation for our findings is that DNA sequence variations in the LEP and LEPR genes induce a mild dysfunction in the leptin-mediated signaling pathway and impair the peripheral effects of leptin [2,3,29] , which is shared by the insulin signal transduction pathway. This pathway is therefore likely to mediate common actions of insulin and leptin as peripheral signals to the central nervous system (CNS) [30,31] , mediating some of the metabolic effects of leptin, particularly with regard to hepatic lipid metabolism [32] . Recently evidence suggests that leptin may down regulate the TG content in liver, skeletal muscle, pancreatic β-cells, and adipose tissue via decreased TG synthesis and enhanced β-oxidation. Leptin production is primarily regulated by insulin-induced changes in adipocyte metabolism. Leptin treatment improves hyperlipidemia in patients with relative leptin deficiency. It has been shown that leptin has a marked protective effect against hyperlipidemia [33,34] . But in type 2 diabetes because of insulin resistance and leptin resistance, the inhibition effect decreases which leads to lipid metabolism disorders. Moreover, elevated plasma leptin levels in type 2 diabetes can regulate the distribution of local body mass that has been justified in many previous studies. These results suggested that such a polymorphism does not usually imply a serious lethal disorder, but it may contribute to the onset of Chinese type 2 diabetes by regulating lipid metabolism and affecting the distribution of local body mass. References [1] M. Wauters R.V. Considine L.F. Van Gaal Human leptin: from an adipocyte hormone to an endocrine mediator Eur J Endocrinol 143 2000 293 311 [2] Y. Minokoshi Y.B. Kim O.D. Peroni L.G. Fryer C. Muller D. Carling Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase Nature 415 2002 339 343 [3] R.H. Unger Lipotoxic diseases Annu Rev Med 53 2002 319 336 [4] Y. Zhang R. Proenca M. Maffei M. Barone L. Leopold J.M. Friedman Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432 [5] S.C. Chua Jr. W.K. Chung X.S. Wu-Peng Y. Zhang S.M. Liu L. Tartaglia Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor Science 271 1996 994 996 [6] H. Chen O. Charlat L.A. Tartaglia E.A. Woolf X. Weng S.J. Ellis Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 84 1996 491 495 [7] K. Clement C. Vaisse N. Lahlou S. Cabrol V. Pelloux D. Cassuto A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 392 1998 398 401 [8] H.M. Lakka L. Oksanen T.P. Tuomainen K. Kontula J.T. Salonen The common pent-nucleotide polymorphism of the 3-untranslated region of the leptin receptor gene is associated with serum insulin levels and the risk of type 2 diabetes in non-diabetic men: a prospective case-control study J Intern Med 248 2000 77 83 [9] M. Wauters R.V. Considine M. Chagnon I. Mertens T. Rankinen C. Bouchard Leptin receptor gene polymorphisms are associated with insulin in obese women with impaired glucose tolerance Obes Res 10 2002 394 400 [10] Y.C. Chagnon W.K. Chung L. Perusse M. Chagnon R.L. Leibel C. Bouchard Linkages and associations between the leptin receptor (LEPR) gene and human body composition in the Quebec Family Study Int J Obes Relat Metab Disord 23 1999 278 286 [11] Y.C. Chagnon J.H. Wilmore I.B. Borecki J. Gagnon L. Perusse M. Chagnon Associations between the leptin receptor gene and adiposity in middle-aged Caucasian males from the HERITAGE family study J Clin Endocrinol Metab 85 2000 29 34 [12] N.D. Quinton A.J. Lee R.J. Ross R. Eastell A.I. Blakemore A single nucleotide polymorphism (SNP) in the leptin receptor is associated with BMI, fat mass and leptin levels in postmenopausal Caucasian women Hum Genet 108 2001 233 236 [13] Y.C. Chagnon T. Rankinen E.E. Snyder S.J. Weisnagel L. Perusse C. Bouchard The human obesity gene map: the 2002 update Obes Res 11 2003 313 367 [14] J. Farhan J. Anila A. Jawaid M.A. Rahman Leptin and blood lipid levels in postmenopausal diabetic women with and without complication of ischemic heart disease Med Sci Monit 12 2006 382 386 [15] R. Tungtrongchitr P. Pongpaew B. Phonrat S. Tribunyatkul D. Viroonudomphol V. Supawan Serum leptin level and lipid profiles in Thai obese and overweight subjects Int J Vitam Nutr Res 71 2001 74 81 [16] A.M. de Silva K.R. Walder T.J. Aitman T. Gotoda A.P. Goldstone A.M. Hodge Combination of polymorphisms in OB-R and the OB gene associated with insulin resistance in Nauruan males Int J. Obes Relat Metab Disord 23 1999 816 822 [17] W.T. Friedewald R.I. Levy D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of a preparative ultracentrifuge Clin Chem 46 1972 499 502 [18] D.F. Blum P. Englaro S. Honitsch Plasma leptin levels in healthy children adolescents. Dependence on body mass index, body fat mass, gender, pubertal stage and testosterone J Clin Endocrinol Metab 82 1997 2904 2908 [19] N. Matsuoka Y. Ogawa K. Hosoda J. Matsuda H. Masuzaki T. Miyawaki Human leptin receptor gene in obese Japanese subjects: evidence against either obesity causing mutation or association of sequence variants with obesity Diabetologia 40 1997 1204 1210 [20] G.M. vander Vleuten L.A. Kluijtmans A. Hijmans H.J. Blom A.F. Stalenhoef J. de Graaf The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia Int J Obes (London) 30 2006 892 898 [21] T.N. Wang M.C. Huang W.T. Chang A.M. Ko E.M. Tsai C.S. Liu G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines Obesity (Silver Spring) 14 2006 183 187 [22] K.S. Park H.D. Shin B.L. Park H.S. Cheong Y.M. Cho H.K. Lee Polymorphisms in the leptin receptor (LEPR)—putative association with obesity and T2DM J Hum Genet 51 2006 85 91 [23] M. Shintani H. Ikegami E. Yamato Y. Kawaguchi T. Fujisawa Y. Nakagawa A novel micro satellite polymorphism in the human ob gene: A highly polymorphic marker for linkage analysis Diabetologia 39 1996 1398 1401 [24] Y.A. Takahashi M. Hiroaki M. Takashi Y. Ogawa T. Hayashi K. Hosoda Association of Ob-R gene polymorphism and insulin resistance in Japanese men Metabolism 53 2004 650 654 [25] Y.A. Takahashi H. Masuzaki T. Miyawaki Y. Ogawa N. Matsuoka T. Hayashi Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men Diab Res Clin Pract 62 2003 169 175 [26] Y.J. Liu S.M. Rocha-Sanchez P.Y. Liu J.R. Long Y. Lu L. Elze Tests of linkage and/or association of the LEPR gene polymorphisms with obesity phenotypes in Caucasian nuclear families Physiol Genomics 17 2004 101 106 [27] C.Y. Liu Y.Q. Wang H.Y. Liu J.F. Ji W.H. Li H.L. Bie Relationship of variation 3057 G → of exon 20 of leptin receptor gene to lipid metabolism and fat distribution of children with obesity Zhonghua Yi Xue Yi Chuan Xue Za Zhi 21 2004 252 256 [28] J.M. Guízar-Mendoza N.L. Amador S.E. Flores-Martínez M.G. López-Cardona R. Ahuatzin-Trémary J. Sánchez-Corona Human leptin association analysis of the Gln223Arg polymorphism in the human leptin receptor gene, and traits related to obesity in Mexican adolescents J Hum Hypertens 19 2005 341 346 [29] J. Seufert T.J. Kieffer C.A. Leech G.G. Holz W. Moritz C. Ricordi Leptin suppression of insulin secretion and gene expression in humanpancreatic islets implications for the development of adipogenic diabetes mellitus J Clin Endocrinol Metab 84 1999 670 676 [30] D. Porte Jr. D.G. Baskin M.W. Schwartz Leptin and insulin action in the central nervous system Nutr Rev 60 2002 S20 S29 [31] K.D. Niswender M.W. Schwartz Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities Front Neuro Endocrinol 24 2003 1 10 [32] P. Cohen M. Miyazaki N.D. Socci P. Cohen M. Miyazaki N.D. Socci Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss Science 297 2002 240 243 [33] P.L. Havel Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism Diabetes 53 2004 S143 S151 [34] J. Kalaivanisailaja V. Manju N. Nanlini Lipid profile in mice fed a high-fat diet after exogenous leptin adiminstration Pol J Pharmacol 55 2003 763 769